Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues

Journal of Cancer Research and Clinical Oncology, Supplement

Volumn 127, Issue 4, 2001, Pages 237-242

  Zhang, W ^a   Rashid, A ^a   Wu, H ^a   Xu, X C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Esophageal cancer; Ki 67; Nuclear retinoic acid receptors; p53

Indexed keywords

BIOLOGICAL MARKER; ISOPROTEIN; KI 67 ANTIGEN; PROTEIN P53; RECEPTOR SUBUNIT; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; RECEPTOR SUBTYPE; TUMOR MARKER; MESSENGER RNA; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE MARKER; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPITHELIUM DYSPLASIA; ESOPHAGUS CANCER; PRECANCER; CHEMISTRY; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY;

ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034741236     PISSN: 09439382     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000183     Document Type: Article

References (44)

1. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
2. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history
3. Esophageal cancer trends and risk factors
4. Nutritional intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population
5. A decade of molecular biology of retinoic acid receptors
6. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
7. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma
8. 2 in F9 cells results in the loss of retinoic acid-associated growth arrest
9. Esophageal cancer
10. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China
11. Cancer statistics, 2000
12. Retinoids, retinoid-responsive genes, cell differentiation, and cancer
13. Highlights of the cancer chemoprevention studies in China
14. Frequent mutation of the p53 gene in human esophageal cancer
15. Recent advances in chemoprevention of cancer
16. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
17. In vivo growth and differentiation potential of tracheal basal cells of rabbits in vitamin A deficiency
18. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: Role of retinoids
19. Development of chemopreventive agents for lung and upper aerodigestive tract cancers
20. Etiology of Barrett's metaplasia and esophageal adenocarcinoma
21. The regulation of p53 function: Steiner award lecture
22. Nutrition intervention trials in Linxian, China: Multiple vitamin/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia
23. Cancer chemoprevention: Progress and promise
24. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin
25. Esophageal cancers: Changing character, increasing incidence
26. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: Correlation with acquisition of the immortal phenotype
27. Retinoids and cancer in experimental animals
28. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis
29. High dose etretinate and interferon-alpha: A phase I study in squamous cell carcinomas and transitional cell carcinomas
30. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid
31. 13-cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: A phase II trial
32. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells
33. Altered p16/MTS1/CDKN2 and cyclin D1/ PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus
34. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function
35. p53 function and dysfunction
36. Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis
37. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
38. Effects of vitamin A deficiency and hypervitaminosis in animals
39. Nonisotopic in situ hybridization for the detection of nuclear retinoid receptor transcripts in tissue sections
40. Aberrant expression and function of retinoic acid receptors in cancer
41. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis
42. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines
43. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention
44. Expression of growth factors and their receptors in human esophageal carcinomas: Regulation of expression by epidermal growth factor and transforming growth factor alpha